ProShares - S&P 500 Ex-Health Care ETF (SPXV) Stock Analysis

ProShares - S&P 500 Ex-Health Care ETF (SPXV) Financial Services Profile

ProShares - S&P 500 Ex-Health Care ETF (SPXV) offers targeted exposure to the S&P 500, strategically omitting the Health Care sector. This ETF enables investors to diversify across various large-cap U.S. industries while maintaining a specific sector underweight, positioning it as a tool for refined portfolio construction within the broader equity market.

What Is the Investment Thesis for SPXV?

ProShares - S&P 500 Ex-Health Care ETF (SPXV) presents a distinct investment vehicle for institutional investors seeking targeted exposure to the U.S. large-cap equity market, specifically excluding the healthcare sector. The fund's value proposition lies in its ability to offer diversification across various industries outside of healthcare, allowing for strategic overweighting in other sectors relative to the overall S&P 500. This focused exposure can be a catalyst for investors looking to implement sector rotation strategies or manage existing healthcare concentrations within their portfolios. With a beta of 1.06, SPXV generally tracks the broader market's volatility, providing a consistent risk profile aligned with large-cap equities. However, its relatively small market capitalization of $40.1M (approximately $38.37 million) introduces potential liquidity risks, which investors must monitor through trading volume and tracking error. The fund's objective to commit at least 80% of its assets to its benchmark ensures high correlation, making it a precise tool for investors aiming to customize their S&P 500 exposure by removing a significant sector component. The ongoing demand for granular portfolio control and sector-specific strategies within the ETF landscape supports SPXV's relevance as a specialized allocation instrument.

Based on FMP financials and quantitative analysis

SPXV Key Highlights

Market capitalization stands at $0.04 billion, indicating a relatively smaller fund size within the ETF landscape.

• The fund exhibits a Beta of 1.06, suggesting it generally moves slightly more than the overall market.
• SPXV does not distribute dividends, aligning with its growth-oriented or specialized index tracking strategy.
• The fund commits a minimum of 80% of its total assets to the S&P 500 Ex-Health Care Index, ensuring high correlation to its specific benchmark.
• Offers focused exposure to large-cap U.S. equities, providing diversification across various industries outside of healthcare.

Who Are SPXV's Competitors?

SPXV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SPXV's Key Strengths?

Provides focused exposure to the S&P 500, excluding the Health Care sector, allowing for strategic allocation.

• Offers diversification across various large-cap U.S. industries outside of healthcare.
• Maintains a high correlation to its benchmark by committing at least 80% of assets to the index.
• Leverages the established reputation and operational expertise of ProShares as an ETF provider.

What Are SPXV's Weaknesses?

Relatively small market capitalization of $40.1M (approximately $38.37 million) may lead to liquidity risks.

• Exclusion of an entire sector could lead to underperformance if the healthcare sector significantly outperforms.
• No dividend yield, which may not appeal to income-focused investors.
• Potential for tracking error relative to its benchmark, which requires ongoing monitoring.

What Could Drive SPXV Stock Higher?

SPXV catalyst: **Increased Investor Focus on Sector Rotation:** As economic cycles evolve, institutional investors are continuously re-evaluating sector allocations.

• A sustained period of underperformance or increased regulatory scrutiny within the healthcare sector could drive capital towards funds like SPXV, which strategically exclude this segment, thereby increasing its assets under management.
• **Growing Adoption of Customized Indexing Strategies:** The trend towards personalized and customized investment solutions is accelerating. As more platforms and advisors offer tools for granular portfolio construction, SPXV's ability to provide a precise 'ex-healthcare' S&P 500 exposure could see increased adoption by investors seeking to fine-tune their market beta.
• **Expansion of the Global ETF Market:** The broader growth of the exchange-traded fund ecosystem continues to be a significant tailwind. As more investors, both retail and institutional, shift from traditional mutual funds to ETFs for their transparency, liquidity, and cost-effectiveness, SPXV is positioned to capture a portion of these overall market inflows.

What Are the Key Risks for SPXV?

**Liquidity Risk due to Small Market Capitalization:** With a market capitalization of $40.1M (approximately $38.37 million), SPXV is a relatively small fund.

• This can lead to lower trading volumes and wider bid-ask spreads, making it more challenging for investors, particularly large institutional ones, to enter or exit positions efficiently without impacting the fund's price.
• **Sector-Specific Underperformance:** By explicitly excluding the healthcare sector, SPXV is inherently exposed to the risk of underperforming a broad S&P 500 index if the healthcare sector experiences a period of significant outperformance. Investors seeking broad market returns without specific sector bets might find this exclusion detrimental to their overall portfolio performance.
• **Tracking Error Risk:** While the fund aims to commit at least 80% of its assets to its benchmark, there is always a potential for tracking error. This means the fund's performance may deviate from that of its underlying index due to factors such as expense ratios, transaction costs, cash drag, or difficulties in replicating the index perfectly, especially with a smaller asset base.
• **Concentration Risk in Remaining Sectors:** By removing healthcare, SPXV inherently increases its concentration in the remaining sectors of the S&P 500. This means that if any of the remaining dominant sectors (e.g., Technology, Financials) experience a downturn, the fund's performance could be more severely impacted than a fully diversified S&P 500 fund.

What Are the Growth Opportunities for SPXV?

• Growth opportunity 1: **Increasing Demand for Granular Sector Exposure:** The ongoing trend among institutional and sophisticated retail investors is a desire for more granular control over their portfolio's sector allocations. As investors become more adept at tactical asset allocation and risk management, funds like SPXV, which allow for the precise removal of a major sector like healthcare from a core S&P 500 position, become increasingly valuable. This allows for customized portfolio construction, enabling investors to underweight healthcare if they anticipate headwinds or already have significant exposure elsewhere. The global market for ETFs continues to expand, with specialized and thematic ETFs capturing a growing share, indicating a sustained demand for such focused products.
• Growth opportunity 2: **Strategic Sector Rotation and Underweighting:** Investors frequently engage in sector rotation strategies based on economic cycles, regulatory changes, or specific industry outlooks. SPXV offers a straightforward mechanism to underweight the healthcare sector without completely abandoning a broad S&P 500 allocation. If market sentiment turns negative on healthcare due to policy changes, drug pricing pressures, or innovation slowdowns, SPXV provides a ready-made solution for rebalancing. This strategic utility positions the fund to benefit from shifts in investor preferences regarding sector exposure, potentially attracting capital from those actively managing their sector bets.
• Growth opportunity 3: **Complementary Portfolio Construction:** For investors who already hold significant direct or indirect exposure to the healthcare sector through other investments (e.g., specialized biotech funds, individual pharmaceutical stocks, or private equity in healthcare), SPXV can serve as a complementary tool. It allows them to maintain a broad S&P 500-like exposure for the rest of their portfolio while avoiding redundant or over-concentrated healthcare positions. This use case addresses the need for diversification and risk management, appealing to sophisticated investors building multi-faceted portfolios, thereby expanding the fund's potential investor base.
• Growth opportunity 4: **Growth of Passive Investing and ETF Adoption:** The broader shift towards passive investment strategies and the increasing adoption of ETFs as primary investment vehicles continue to provide a tailwind for all ETFs, including specialized ones like SPXV. Investors are increasingly favoring the transparency, liquidity, and generally lower expense ratios of ETFs compared to traditional mutual funds. As the overall ETF market expands globally, SPXV stands to benefit from this secular trend, attracting capital from new investors entering the market and existing investors reallocating from other investment products into the ETF wrapper.
• Growth opportunity 5: **Enhanced Risk Management and Diversification:** By excluding the healthcare sector, SPXV offers a distinct risk profile compared to a standard S&P 500 fund. This can be a growth driver for investors seeking to mitigate specific risks associated with the healthcare industry, such as regulatory uncertainty, patent cliffs, or the high costs of drug development. For investors concerned about the concentration of certain large-cap healthcare companies within the S&P 500, SPXV provides a way to diversify away from those specific influences while still participating in the broader U.S. equity market. This risk management utility can attract risk-averse or strategically focused investors.

What Threats Does SPXV Face?

• Intense competition from other ETF providers offering similar broad market or sector-specific funds.
• Sustained strong performance of the healthcare sector could lead to underperformance compared to a full S&P 500 index.
• Regulatory changes impacting the asset management industry or specific sectors could affect fund performance.
• Low trading volume due to small market cap could exacerbate liquidity issues during periods of market stress.

What Are SPXV's Competitive Advantages?

• Leverages the widely recognized and trusted S&P 500 brand for its underlying index, enhancing credibility.
• Offers a unique and specific exclusion (ex-Health Care) that caters to a defined investor need for customized exposure.
• Benefits from the operational efficiency and scale of ProShares as an established ETF provider.
• Provides a liquid and transparent investment vehicle through its ETF structure, appealing to a broad investor base.

What Does SPXV Do?

ProShares - S&P 500 Ex-Health Care ETF (SPXV) is an exchange-traded fund designed to provide investors with investment exposure to a modified version of the S&P 500 index. The core objective of SPXV is to track the performance of companies included in the S&P 500, with the distinct exclusion of those classified within the Health Care Sector. This specialized approach allows investors to gain broad market exposure to large-cap U.S. equities while strategically underweighting or completely avoiding the healthcare industry. Under typical market conditions, the fund commits a minimum of 80% of its total assets to the securities that constitute this specific underlying index, ensuring alignment with its stated investment objective. ProShares, a prominent provider of ETFs, launched this fund to cater to investors seeking more granular control over their sector allocations within a core S&P 500 strategy. The fund's structure as an ETF provides daily liquidity and transparency, characteristic benefits of the ETF wrapper. By focusing on the S&P 500 ex-Health Care, SPXV offers a unique proposition for portfolio managers and individual investors who may already have sufficient healthcare exposure, or who hold a bearish view on the sector, or simply wish to rebalance their sector weights without deviating entirely from a broad market benchmark. The fund's underlying index is maintained by S&P Dow Jones Indices, ensuring a systematic and rules-based approach to constituent selection and weighting. Headquartered in Bethesda, US, ProShares manages a diverse suite of ETFs, leveraging its expertise in creating innovative investment products for various market segments.

What Products and Services Does SPXV Offer?

• Tracks the performance of the S&P 500 index, specifically excluding companies within the Health Care Sector.
• Invests a minimum of 80% of its total assets in the securities that comprise its underlying index.
• Provides investors with focused exposure to large-cap U.S. equities across various industries, excluding healthcare.
• Offers a mechanism for investors to underweight or avoid the healthcare sector while maintaining broad market participation.
• Serves as an exchange-traded fund (ETF), providing daily liquidity and transparency to investors.
• Aims to replicate the performance of its specialized benchmark, the S&P 500 Ex-Health Care Index.
• Facilitates tactical asset allocation strategies by allowing for precise sector exclusion within a core equity holding.

How Does SPXV Make Money?

• Generates revenue primarily through management fees charged to investors for managing the fund.
• Aims to track its underlying index passively, minimizing active management costs.
• Benefits from asset gathering, as increased assets under management (AUM) directly translate to higher fee income.
• Relies on the demand for specialized index-tracking products within the ETF market.

What Industry Does SPXV Operate In?

SPXV operates within the highly competitive and rapidly expanding global asset management industry, specifically leveraging the growth of exchange-traded funds (ETFs). The asset management sector, particularly the ETF segment, has seen substantial inflows driven by demand for cost-effective, transparent, and liquid investment vehicles. SPXV's niche is providing sector-specific exclusion within a broad market index, catering to investors who desire more granular control than traditional S&P 500 index funds. This positions it against both broad market ETFs and other sector-specific funds. The competitive landscape includes major ETF providers offering various S&P 500 variations, including those with sector tilts or exclusions. Market trends indicate a continued preference for passive investment strategies and thematic or factor-based ETFs, which SPXV, with its defined exclusion, partially addresses. Its strategy allows it to capture flows from investors performing sector rotation or managing concentrated positions, distinguishing it from generic S&P 500 trackers.

Who Are SPXV's Key Customers?

• Institutional investors such as pension funds, endowments, and asset managers seeking specific sector exposure.
• Financial advisors and wealth managers constructing diversified client portfolios.
• Individual investors looking for targeted exposure or to manage existing sector concentrations.
• Investors implementing sector rotation strategies or seeking to underweight the healthcare sector.

ProShares - S&P 500 Ex-Health Care ETF (SPXV) Valuation Context

Valued at $40.1M, SPXV is classified as a micro-cap stock.

Return on equity for ProShares - S&P 500 Ex-Health Care ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. SPXV trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

SPXV Financials

SPXV Latest News

No recent news available for SPXV.

SPXV Analyst Consensus

SPXV MoonshotScore

ProShares - S&P 500 Ex-Health Care ETF Financial Services Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources